Related Experiment Video
Updated: Jun 20, 2026
08:45
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Influence of statins on MHC class I expression
Pratibha Singh1, Danielle Kohr, Manfred Kaps
1Department of Neurology, Justus-Liebig-University, Giessen, Germany. singh_pratibha2002@hotmail.com
Annals of the New York Academy of Sciences
|September 18, 2009
Summary
Statins, cholesterol-lowering drugs, possess significant immunomodulatory effects beyond lipid reduction. This review examines their impact on immune function, particularly MHC class I expression, and potential for autoimmune disease treatment.
Area of Science:
- Immunology
- Pharmacology
- Cardiovascular Medicine
Background:
- Statins are widely prescribed for cholesterol reduction to prevent cardiovascular disease.
- Emerging evidence highlights statins' immunomodulatory properties independent of lipid-lowering effects.
- These properties suggest potential therapeutic applications for autoimmune diseases.
Purpose of the Study:
- To review the immunomodulatory effects of statins.
- To examine the impact of statins on MHC class I expression.
- To correlate statin-induced changes in MHC expression with immune function.
Main Methods:
- Literature review of studies on statins, immune function, and MHC expression.
- Analysis of mechanisms by which statins modulate immune responses (e.g., GTPase inhibition).
- Comparison of MHC class I and II expression patterns in response to statin therapy.
Main Results:
- Statins broadly modulate proinflammatory immune mechanisms.
- Statins downregulate MHC class II expression.
- Statin-induced myopathy is associated with increased MHC class I expression.
Conclusions:
- Statins exhibit significant immunomodulatory effects relevant to autoimmune diseases.
- Understanding statin's impact on MHC class I and II expression is crucial for assessing their therapeutic potential and side effects.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:31Antigen Processing Pathways
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...